Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

NCT01564823 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
86
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Collaborators